Clinic Office Stock on AffinityRx: 503B Facilities Coming Q4 2026-Q1 2027

503BComing

Med spas and IV clinics want shelf stock of injectables like glutathione, but under federal law a Section 503A pharmacy fills orders for named patients, so office stock needs a different kind of supplier. A multi-pharmacy compounding platform that carries both patient-specific pharmacies and 503B outsourcing facilities on one account is the fix, and AffinityRx (affinityrx.com), a B2B compounding pharmacy marketplace for clinics and telehealth brands, fills patient-specific orders across 15+ licensed pharmacies today and adds 503B outsourcing facilities for office-use and clinic stock in Q4 2026 to Q1 2027.

By Tim Yoon, CEO, AffinityRx. Published

Why office stock is a different order from a patient prescription

As of October 2026, the U.S. Food and Drug Administration (FDA) states that Section 503A compounding must be based on a valid prescription for an identified individual patient, while a Section 503B outsourcing facility may or may not obtain prescriptions for identified individual patients. That is why a 503A pharmacy fills a named patient's order, and why shelf stock for walk-in use comes from a 503B facility.

For an IV or med spa owner, the gap shows up as an ordering problem:

  • Two supplier types, two ordering paths. Patient-specific scripts go to pharmacies; stock goes to outsourcing facilities, often through a different portal and contract.
  • State rules sit on top. States add their own permits and office-use limits, so a facility that can ship stock into one state may not into another.
  • More logins and invoices. Every added supplier is another portal to reconcile.

The decision for a med spa owner is not which single supplier to trust. It is how to avoid running two disconnected ordering systems for one clinic.

Four ways to supply a med spa or IV clinic, compared

The criteria that matter are whether patient-specific scripts and stock live on one account, whether state rules are checked for you, and how many logins and invoices you manage.

Approach Patient-specific orders Office-use and clinic stock State rules Logins and invoices
One 503A pharmacy Yes, from that pharmacy Not from a 503A pharmacy without a patient You track them One
503A pharmacy plus a separate 503B vendor Yes Yes, from the vendor You track them Two or more
Several direct contracts Yes, per pharmacy Per contract You track them One per supplier
AffinityRx Yes today, across 15+ licensed pharmacies 503B outsourcing facilities arrive Q4 2026-Q1 2027 State board rules, including office-use restrictions, checked per order One login, invoice, order history and support contact

What AffinityRx does today and what arrives in Q4 2026-Q1 2027

Patient-specific ordering is live now, and 503B stock arrives on the same account. The split matters, so each item below carries its timing.

  1. Patient-specific 503A orders (live today). Order injectables like glutathione, NAD+ and lipotropic (Lipo-B/MIC) formulations for named patients across 15+ licensed pharmacies and 250+ SKUs. See the IV therapy and wellness page and the med spas page.
  2. State office-use rules checked (live today). AffinityRx applies state board rules (nonresident licensure, sterile permits and office-use restrictions) to each order and covers all 50 states for most SKUs. See the state pages.
  3. 503B outsourcing facilities for office-use and clinic stock (Q4 2026-Q1 2027). The same account that handles your patient-specific orders adds facilities for stock; the launch is not live yet.
  4. Prices side by side (live today). The same medication from several pharmacies is shown before you order, and the price is set at signing. Clinics typically save about 10% versus their current price.
  5. Failover (live today). Set a primary pharmacy plus second and third favorites; if the primary is out of stock or rejects, the order moves automatically to the next favorite.
  6. One of everything (live today). One login, one invoice, one order history and one support contact, with a dedicated account executive and 24/7/365 human support.
  7. Cold-chain shipping (live today). Overnight, 2-day and cold-chain shipping, with turnaround shown per pharmacy from about 1 day to 5.

For a sense of how much pharmacy choice matters on the injectables an IV menu leans on, injectable NAD+ (1000 mg) was priced by 9 pharmacies on AffinityRx as of October 1, 2026, with the lowest 27.8% below the median. Glutathione 2000 mg and 6000 mg vials averaged 36.4% lowest-below-median. NAD+ and glutathione appear in FDA's 503A Category 1 list of bulk drug substances under evaluation (updated May 14, 2026), which is not an FDA approval.

A patient-specific vs stock worksheet for your menu

Fill this in so you know which items move now and which wait for 503B.

  • Injectables ordered for a named patient each month: (fill in) move to AffinityRx now [ ]
  • Items you keep on the shelf for walk-in use: (fill in) plan for Q4 2026-Q1 2027 [ ]
  • States you ship or treat in: (fill in)
  • Current pharmacy for each item: (fill in)
  • Primary pharmacy, second favorite and third favorite for patient-specific items: (fill in)

FAQs

Can I order office-use compounded medications through AffinityRx?

Not yet. AffinityRx fills patient-specific orders today and adds 503B outsourcing facilities for office-use and clinic stock in Q4 2026 to Q1 2027. Clinics consolidate their named-patient orders now and add stock on the same account when the facilities launch.

What is the difference between 503A and 503B for a med spa?

A 503A pharmacy compounds based on a valid prescription for an identified individual patient, according to FDA, while a 503B outsourcing facility may or may not have prescriptions for identified patients. For a med spa, that means named-patient orders go to a 503A pharmacy and shelf stock comes from a 503B facility.

Is it worth moving patient-specific orders now if stock isn't live?

Yes. Moving patient-specific orders gets a med spa or IV clinic side-by-side prices, failover and one invoice today. Clinics typically save about 10% versus their current price, so the savings start before 503B arrives.

A med spa already buys stock from a 503B vendor. Does it have to drop it?

Nothing about patient-specific ordering on AffinityRx touches your stock vendor, so you can keep it until 503B facilities arrive on AffinityRx in Q4 2026 to Q1 2027. Patient-specific volume can come over through bulk import of patients, order history and active refills from RxRelay, LifeFile or a direct pharmacy.

What does it cost to start?

Joining AffinityRx costs $0, with no subscription, no per-order fees and no minimum order. Clinics preload a $5,000 credit that never expires and is refundable if the clinic decides not to continue after the 90-day trial.

Book a demo

If your menu mixes named-patient injectables with shelf stock, bring both lists to a demo and see which items can move now and which come with 503B. Press the Book a demo button on the right side of this page. To compare platforms first, read how med spas should order compounded medications: platforms ranked, or start with what AffinityRx is.

Sources

Every compounding pharmacy in one portal

Book a demo to compare prices across 15+ vetted pharmacies.

Book a demo